EquiCord is a multidisciplinary company formed by veterinarians, researchers and engineers dedicated to the research & development, manufacturing and commercialization of Stem Cell based medicines for animals.
In 2019, we obtained the European Marketing Authorization of the fisrt and unique pure Mesenchymal Stem Cell veterinary medicine worldwide: HorStem.
Recently , we submitted for centralized MA, DogStem, the first Stem Cell based medicine for the treatment of pain and lameness in canine OA.
EquiCord's mission is to develop afforable, innovative, highly effective, safe and regenerative advanced therapies medicines available to all the animals worldwide.
Our regulatory department is preparing the expansion of HorStem and DogStem to the USA, Middle East, Asia and Latin America. We offer our services on a global basis with maximum efficiency and quality standards.
Company Details
- Employees
- 16
- Founded
- -
- Address
- Calle De Loeches, 103d, Alcorcón,comunidad De Madrid 28925,spain
- Industry
- Veterinary Services
- NAICS
-
Veterinary Services
- Website
- equicord.com
- Keywords
- Advance Therapies, Stem Cells, Veterinary Medicine, Clinical Trials, R&D, One Health, Osteoarthritis, Veterinary Drugs Development.
- HQ
- Alcorcón, Comunidad de Madrid
Equicord Questions
Equicord's website is equicord.com
Equicord's LinkedIn profile is https://es.linkedin.com/company/equicord
Equicord has
16 employees.
View email and phone details for 16
employees at Equicord.
Equicord's industry is
Veterinary Services
Equicord's top competitors are
Imereti,
Bioiberica,
Diater,
Biocells Discoveries,
Biocord | Células Madre,
Unolab Manufacturing,
Pharmamar,
Inmunotek,
Msd España,
Grupo Alter.
Equicord's categories are Veterinary Services
Equicord's founding year is 2012
